Clinical Trial Update: Fecal Microbiota Transplantation for Primary Clostridium Difficile Diarrhea [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating fecal microbiota transplantation for primary Clostridium difficile diarrhea was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridium Difficile Infection

Snippet

Sponsor: Memorial University of Newfoundland | Conditions: Clostridium Difficile | Phase 3 | Status: WITHDRAWN